Foamix Pharmaceuticals Ltd. Net Income
Foamix Pharmaceuticals Ltd. reported Net Income of -$95.18 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for the quarter ending 2019-12-31 was -$37.82M.
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for the quarter ending 2019-09-30 was -$23.16M.
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for the quarter ending 2019-06-30 was -$18.99M.
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for the quarter ending 2019-03-31 was -$15.20M.
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for fiscal 2019 was -$95.18M.
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for fiscal 2018 was -$74.16M.
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for fiscal 2017 was -$65.72M.
- Foamix Pharmaceuticals Ltd. net income (loss) attributable to parent for fiscal 2016 was -$29.34M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$37.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$60.98M derived: sum of 2 quarters · filed 2020-03-12 | -$79.97M derived: sum of 3 quarters · filed 2020-03-12 | -$95.18M 10-K · filed 2020-03-12 |
| 2019-09-30 | -$23.16M 10-Q · filed 2019-11-12 | -$42.15M derived: sum of 2 quarters · filed 2019-11-12 | -$57.36M 10-Q · filed 2019-11-12 | -$71.44M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | -$18.99M 10-Q · filed 2019-08-07 | -$34.20M 10-Q · filed 2019-08-07 | -$48.27M derived: sum of 3 quarters · filed 2020-03-12 | -$63.76M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | -$15.20M 10-Q · filed 2019-05-07 | -$29.28M derived: sum of 2 quarters · filed 2020-03-12 | -$44.76M derived: sum of 3 quarters · filed 2020-03-12 | -$63.39M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | -$14.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$29.56M derived: sum of 2 quarters · filed 2020-03-12 | -$48.19M derived: sum of 3 quarters · filed 2020-03-12 | -$74.16M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$15.48M 10-Q · filed 2019-11-12 | -$34.11M derived: sum of 2 quarters · filed 2019-11-12 | -$60.09M 10-Q · filed 2019-11-12 | -$77.45M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$18.63M 10-Q · filed 2019-08-07 | -$44.60M 10-Q · filed 2019-08-07 | -$61.97M derived: sum of 3 quarters · filed 2020-03-12 | -$79.55M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$25.98M 10-Q · filed 2019-05-07 | -$43.34M derived: sum of 2 quarters · filed 2020-03-12 | -$60.92M derived: sum of 3 quarters · filed 2020-03-12 | -$77.31M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$17.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$34.94M derived: sum of 2 quarters · filed 2020-03-12 | -$51.33M derived: sum of 3 quarters · filed 2020-03-12 | -$65.72M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$17.58M 10-Q · filed 2018-11-07 | -$33.97M derived: sum of 2 quarters · filed 2018-11-07 | -$48.35M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$16.39M 10-Q · filed 2018-08-08 | -$30.77M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$14.38M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$29.34M 10-K · filed 2019-02-28 | |||
| 2016-06-30 | -$8.19M 6-K · filed 2017-08-08 | -$12.70M 6-K · filed 2017-08-08 | ||
| 2015-12-31 | -$16.52M 10-K · filed 2018-03-01 | |||
| 2015-06-30 | -$4.65M 6-K · filed 2016-08-10 | -$7.73M 6-K · filed 2016-08-10 | ||
| 2014-12-31 | -$11.48M 20-F · filed 2017-02-21 | |||
| 2014-06-30 | -$3.43M 6-K · filed 2015-10-19 | -$3.47M 6-K · filed 2015-10-19 | ||
| 2013-12-31 | -$2.43M 20-F · filed 2016-03-02 | |||
| 2012-12-31 | -$2.17M 20-F · filed 2015-03-17 |